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Background
gamma-Aminobutyric acid (GABA) plays an important role as an inhibitory neurotrans-
mitter of the central nervous system (Gajcy et al. 2010). Impaired secretion of GABA is 
associated with several important neurological disorders such as Parkinson’s (Kleppner 
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and Tobin 2001) and Alzheimer’s disease (Jo et  al. 2014) and other psychiatric disor-
ders (Nutt and Malizia 2001). Amyloid-β (Aβ) is an intrinsically disordered protein and 
therefore, it does not have an ordered native structure under physiological condition (Lu 
et al. 2013). However, the structure of Aβ evolves or gets stabilized as it forms higher 
order aggregates (Lu et al. 2013) such as oligomers and thread like elongated fibril with 
cross beta sheet structure. Therefore, the binding sites on Aβ also evolve with the pro-
cess of aggregation. Drugs that bind to amyloid beta at different stages of aggregation 
have been developed to arrest the further growth of oligomers (Padayachee and White-
ley 2011; Huy et al. 2013; Richard et al. 2013).
New GABA derivatives can be considered as potential drugs in the treatment of neu-
rodegenerative disorders (Gajcy et al. 2010). The efficacy of GABA can be highly poten-
tiated by benzodiazopines (Nutt and Malizia 2001). Recently there has been increasing 
interest in synthesizing new GABA derivatives, thus, these compounds could be the 
potential lead molecules in the development of anti-Alzheimer’s drugs to target Aβ pep-
tide or its assembly structures (Jiang et al. 2013).
To realize the interaction pattern of the newly synthesized GABA derivative, methyl 
4-(4-((2-(tert-butoxy)-2-oxoethyl)(4-methoxyphenyl)amino)benzamido)butanoate, in 
hydrophobic protein cavities we explored both the quantitative and qualitative aspects 
of the interaction and incorporation of the compound into the binding pockets of serum 
albumin using fluorescence, molecular docking and molecular dynamics analysis. This 
compound is very similar to a series of molecules which were previously tested by Dr. 
Banerji’s group for their anti-Alzheimer’s activity (Sanphui et al. 2013).
The incorporation and investigation of the molecule inside the hydrophobic protein 
environment was monitored following the changes in the intrinsic tryptophan fluores-
cence of the protein molecule. Intrinsic protein fluorescence originating from trypto-
phan and tyrosine residues provides ample information about the local environment, the 
changes in protein conformation and the interaction of a protein with a drug molecule 
(Möller and Denicola 2002). Perturbation in fluorescence intensity also provides sig-
nificant insight into the interaction pattern of the molecules. Binding parameters were 
measured from fluorescence quenching in the presence of the compound and related 
thermodynamic parameters were obtained by measuring the effect of temperature on 
binding constant.
In addition, to find out the interaction of the drug molecule at atomic level, molecu-
lar docking and dynamics analysis were carried out. Molecular docking is a robust and 
efficient computational technique to understand the structure activity relationship of a 
drug-like molecule with a target protein (Jorgensen 2004; Morris and Lim-Wilby 2008; 
Meng et al. 2011). The binding sites of the GABA derivative on serum albumins, inter-
acting residues and the type of interactions were probed by molecular docking analysis. 
Molecular dynamics study further ascertained the stability of binding and highlighted 
the specific interactions over a time period.
Methods
Chemicals
Bovine and human serum albumins were purchased from Sigma-Aldrich Corporation 
(St. Louis, MO, USA). Tris–HCl and Urea were also purchased from Sigma-Aldrich. All 
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the samples were prepared in 20 mM Tris–HCl buffer of pH 7.0. Deionized and triple 
distilled water was used for preparing buffer solution that was passed through 0.22 µm 
pore size Millipore filters (Millipore India Pvt. Ltd., Bangalore, India).
All air and water sensitive reactions were carried out in oven dried glassware under 
nitrogen atmosphere using standard manifold techniques. All the chemicals were pur-
chased from Acros organics and Sigma-Aldrich, and used without further purification 
unless otherwise stated. Compounds that are not described in the experimental part 
were synthesized according to the literature procedures. Solvents were freshly distilled 
by standard procedures prior to use. Flash chromatography was performed on silica gel 
(Merck, 100–200 mesh) with the indicated eluant. All 1H and 13C-NMR spectra were 
recorded on a Bruker 600  MHz spectrometer. For 1H NMR, tetramethylsilane (TMS) 
served as internal standard (δ = 0) and data are reported as follows: chemical shift, inte-
gration, multiplicity (s = singlet, d = doublet, t =  triplet, q = quartet, m = multiplet) 
and coupling constant(s) in Hz. For 13C NMR, TMS (δ = 0) or CDCl3 (δ = 77.26) was 
used as internal standard and spectra were obtained with complete proton decoupling.
Procedure to synthesize the GABA derivative
Synthesis of the compound methyl 4-(4-((2-(tert-butoxy)-2-oxoethyl)(4-methoxyphenyl)
amino)benzamido)butanoate was carried out following Scheme  1. Detailed procedure 
and characteristic data are given in the supporting information.
Absorption spectroscopy
Ground-state absorption spectra were recorded with a Shimadzu UV-2401PC Spec-
trometer. 1 cm path-length quartz cuvette was used and 250–450 nm wavelength range 
was scanned.
Fluorescence emission spectroscopy
The steady-state fluorescence emission and excitation spectra were recorded with a Cary 
Eclipse Fluorescence Spectrophotometer. The emission spectra of serum albumins were 
obtained by exciting the samples at the wavelength 295 nm. In all the cases, the excita-
tion and emission slit widths were kept at 5 nm each. Protein fluorescence spectra as a 
function of ligand concentration was recorded by a simple titration method (Banerjee 
et al. 2012, 2013; Ray et al. 2012).
Determination of binding constants
The intrinsic fluorescence of protein was measured as a function of ligand concentra-
tion. The protein concentration was kept at 0.5  µM and the ligand concentration was 
varied from 0 to 5.5 µM. Small dilution error due to the titration was ignored. For the 
titration experiment, we used 100 µM stock solution of compound 5 in same buffer from 
which we added 10 µL compound 11 times to 2000 µL protein solution amounting to a 
maximum of 5.5 % dilution. Fluorescence intensities at maximum emission wavelength 
were recorded as a function of ligand concentration. To derive the binding parameters, 
data were analyzed using the non-linear Langmuir isotherm (Banerji et al. 2013):
(1)�F = �Fmax ∗ [Q]/(Kd + [Q])
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where ΔF is the difference in fluorescence in the absence and presence of the quencher 
at concentration [Q], ΔFmax is the maximum possible change in the fluorescence inten-
sity, Kd is the binding dissociation constant. The non-linear equation was fitted to the 
data using Wolfram Mathematica 9. Stern–Volmer quenching constant or the binding 
affinity constant, Ka was determined as a reciprocal of Kd (Banerji et al. 2013).
Binding thermodynamics
Kd values were determined as a function of temperature and the thermodynamic param-
eters of binding were obtained by fitting van’t Hoff equation (Banerjee et al. 2012; Ray 
et al. 2012) to the data:
where Keq is the equilibrium constant (here the Stern–Volmer quenching constant) of 
binding at corresponding temperature T, and R is the gas constant. The equation gives 
the standard enthalpy change (ΔH°) and standard entropy change (ΔS°) on binding. The 
free energy change (ΔG°) has been estimated from the following relationship (Banerjee 
et al. 2012; Ray et al. 2012):
Lipophilicity and solubility calculations
Lipophilicity in terms of calculated logP (clogP) and solubility in terms of calculated logS 
(clogS) were determined at Virtual Computational Chemistry Laboratory server (http://
(2)ln Keq = −�H
◦/RT+�S◦/R
(3)G◦ = H◦ − TS◦
Scheme 1 Reagent and conditions: a Conc. H2SO4, MeOH, 0 °C to r.t., 6 h. b Palladium(II) acetate (0.05 equiv.), 
xantphos (0.1 equiv.) and cesium carbonate (3 equiv.), 80 °C, 4 h. c Potassium tert-butoxide (1.2 equiv.), DMF, 
0 °C to r.t., 12 h. d Lithium hydroxide (3 equiv.), MeOH–water (5:1), r.t., 2 h. e EDC.HCl (3.0 equiv.), HOBT (2.5 
equiv.), TEA (6 equiv.), 0 °C to r.t., 1.5 h
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www.vcclab.org/lab/alogps/) (Tetko et al. 2005). Polar surface area was calculated with a 
1.4 Å radius probe size.
Molecular docking
Molecular docking experiments were performed using four different algorithms: Auto-
Dock Vina (Trott and Olson 2010), AutoDock 4.2 (Morris et  al. 2009), PatchDock/
FireDock (Schneidman-Duhovny et  al. 2005; Mashiach et  al. 2008) and SwissDock 
(Grosdidier et al. 2011). BSA (PDB: 3V03) (Majorek et al. 2012) and HSA (PDB: 4L8U) 
(Bhattacharya et al. 2000) structural information was obtained from Protein Data Bank 
(Berman et al. 2000). Protein structures were chosen based on the validation report pro-
vided by wwPDB at the PDB website (Read et al. 2011; Gore et al. 2012). All the hetero 
atoms and water and multiple subunits were removed from the PDB structures and the 
missing side chain residues for BSA were modeled at PDB_hydro web server (Azuara 
et  al. 2006). The ligand structures were drawn in Avogadro (Hanwell et  al. 2012) and 
geometry optimized in vaccuo using the steepest descent followed by conjugate gradient 
algorithms in UFF forcefield as implemented in Avogadro.
AutoDockTools (Morris et al. 2009) was used to prepare the ligand and proteins For 
the docking in AutoDock 4.2 and AutoDock Vina. Polar hydrogen atoms and Gasteiger 
charges were added to the proteins and the ligand. All the rotatable bonds in the ligand 
were set free. No flexibility was added to the protein side chains. The whole protein was 
placed in the center of a simulation box. The box dimension was 87 × 66 × 80 cubic 
angstroms for BSA and 87 × 66 × 73 cubic angstroms for HSA. Grid point spacing of 
0.775 Å was used for docking in AutoDock 4.2, while the grid point spacing for Auto-
Dock Vina was 1 Å. Genetic algorithm was run (ga_run) 100 times to generate a statisti-
cally significant number of docked poses (Alam et  al. 2012). All the other parameters 
were kept constant. AutoDock Vina results were rendered in PyMOL and AutoDock 4.2 
results were rendered in MGLTools.
Docking was also carried out at two different web servers: SwissDock and Patch-
Dock/FireDock. SwissDock results were rendered in UCSF Chimera (Pettersen et  al. 
2004). PatchDock does not consider ligand flexibility, therefore, best poses of the ligand 
obtained by AutoDock 4.2, Vina and SwissDock were used as input ligand orientation 
for docking with PatchDock. 10 Best PatchDock results were further refined by Fire-
Dock web interface. FireDock results were rendered in PyMOL.
Molecular dynamics
Molecular dynamics (MD) analysis was carried out in Schrodinger Maestro Molecular 
Modeling environment (academic release 2015-4). 12 ns dynamics were carried out for 
the protein ligand complexes and for the proteins as well, in SPC water environment 
using Desmond (Bowers et  al. 2006) molecular dynamics program implemented in 
Schrodinger Maestro. The proteins or the complexes were placed in the center of the 
simulation box with periodic boundary conditions. The periodic boundary box dimen-
sions are given in the supporting information (Additional file  1: Table S1). The whole 
systems were charge neutralized using sodium ions. MD was run in OPLS 2005 force 
field (Banks et  al. 2005). Five step relaxation protocol was used starting with Brown-
ian dynamics for 100 ps with restraints on solute heavy atoms at NVT (with T = 10 K) 
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followed by 12  ps of dynamics with restraints at NVT (T  =  10  K) and then at NPT 
(T = 10 K) using Berendsen method. Then the temperature was raised to 300 K for 12 ps 
followed by 24 ps relaxation step without restraints on the solute heavy atoms. The pro-
duction MD was run at NPT with T =  300 K for 12,000 ps. The molecular dynamics 
output was rendered in Schrodinger Maestro Suite.
Results and discussion
Absorbance and fluorescence of the GABA derivative
Molecular structure of compound 5 is shown in Scheme 1. Additional file 1: Figure S1 
shows the absorption spectrum of the GABA derivative. Due to the presence of conju-
gate systems, it showed absorption in UV region (below 300 nm). However, the absorb-
ance was very weak. The compound is non-fluorescent in nature.
Interaction with albumins
The fluorescence intensity of BSA and HSA decreased gradually with the increasing 
concentration of ligand (Fig. 1). Thus, the quenching of the intrinsic tryptophan fluores-
cence of serum albumins by the GABA derivative indicates its binding to the proteins. 
Figure 2 shows the Langmuir isotherm (Eq. 1) fitted to the quenching data for the deter-
mination of binding constants. The binding dissociation constants were found to be in 
the low micromolar concentration range (Table 1). Ligand shows a negligible absorbance 
at 295 nm wavelength. However, the experiments were carried out at very low concen-
trations of protein and ligand to avoid the inner filter effect.
Thermodynamics of serum albumin binding
Equilibrium constant of a reaction changes with the temperature (Fig.  3), which 
is explained by van’t Hoff’s equation. The standard enthalpy and standard entropy 
changes for the reaction can also be obtained from van’t Hoff’s equation. The tem-
perature depended fluorescence quenching study showed that the association of com-
pound 5 with serum albumins is thermodynamically favorable, which is evident from 
the decrease in Gibbs free energy (Table 2). However, the binding with HSA was found 
to be enthalpy driven (negative ΔH°) whereas the binding with BSA was entropy driven 
Fig. 1 Fluorescence quenching of BSA and HSA with the GABA derivative. Serum albumin concentration was 
kept constant at 0.5 μM (in 20 mM Tris–HCl buffer of pH 7.0) and the ligand concentration was varied from 0 
to 5.5 μM. a Spectral changes showing the quenching of intrinsic fluorescence emission of BSA as a function 
of ligand concentration. b Quenching of intrinsic fluorescence of HSA in presence of ligand. These two spec-
tra were recorded at room temperature
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(positive ΔS°). It suggests that, despite the structural similarity between the two proteins, 
the interactions with HSA are thermodynamically different from those with BSA. The 
similar trend was also observed for the binding of a naphthalene based fluorescent com-
pound we previously reported (Pal et  al. 2015). The molecule under investigation has 
structural similarity with the previously reported molecule, however, it contains a phe-
nyl substituent instead of a naphthyl group. 
Fig. 2 Determination of binding constants of the compound with serum albumins. a The changes in fluores-
cence intensity at the maximum emission wavelength and the fitted Langmuir isotherm for the determina-
tion of binding constant with BSA. b Langmuir isotherm for HSA binding
Table 1 The Kd and  Ka values for  the binding of  the GABA derivative to  serum albumins 
as determined by the fluorescence quenching experiments at room temperature
Protein Kd (M) Ka (M
−1)
BSA 3.85 × 10−6 2.60 × 105
HSA 2.75 × 10−6 3.64 × 105
Fig. 3 Determination of thermodynamic parameters of binding from van’t Hoff’s plot. a Decrease in the 
binding equilibrium constant with the decreasing temperature (303, 298 and 293 K) for the interaction with 
BSA and the fitted van’t Hoff equation. b Increase in the binding equilibrium constant with the decreasing 
temperature (308, 298 and 288 K) for the interaction with HSA and the fitted van’t Hoff equation
Table 2 Thermodynamics of the GABA derivative binding to serum albumins
Serum albumins ΔG° (kJ mol−1) at 25 °C ΔH° (kJ mol−1) ΔS° (J mol−1 K−1)
BSA −29.27 37.08 222.67
HSA −31.34 −10.63 69.5
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Drug like properties of the GABA derivative
The molecular properties of the compound such as clogP, clogS, and polar surface area 
(Bickerton et al. 2012) are listed in Table 3. The clogP value of a compound is the loga-
rithm of its partition coefficient between n-octanol and water. It is a well established 
measure of the compound’s lipophilicity, which influences its behaviour in a range of 
biological processes such as solubility, membrane permeability, lack of selectivity and 
non-specific toxicity (Alam et al. 2011). It has been shown for compounds to have a rea-
sonable probability of being well absorbed, their logP value must not be greater than 5.0 
(Lipinski et al. 1997). Besides, the aqueous solubility of a compound is also defined by 
logS, which significantly affects its absorption and distribution characteristics. Typically, 
a low solubility goes along with a bad absorption. Most of the drugs on the market have 
an estimated logS value of about −4. Table 3 lists the polar surface area of the compound 
as well, which should be less than 140 Å2 for a drug molecule (Lipinski et al. 1997). Apart 
from lipophilicity/solubility and the polar surface area, the molecular weight and the 
number of hydrogen bond acceptor/donor in the compound also follow the Lipinski’s 
rule of five (Lipinski et al. 1997).
Molecular modeling provides insight into the interaction with serum albumins
It has been established that serum albumin proteins have at least seven hydrophobic 
grooves on their surface that provide a unique microenvironment and act as universal 
receptors for many drug molecules (Curry et al. 1998; Simard et al. 2006; Reichenwall-
ner and Hinderberger 2013). Binding to these hydrophobic sites increases the solubil-
ity of hydrophobic ligands in plasma and modulates their delivery to cells. The precise 
architecture of the binding pockets is known from several crystallographic and NMR 
spectroscopic studies (Curry et  al. 1998; Simard et  al. 2006; Hamilton 2013). To gain 
a better insight into the interactions of compound 5 with serum albumins molecular 
docking and dynamics analysis were carried out. Four different algorithms were used 
to find the binding site of compound 5 on serum albumins: AutoDock 4.2, AutoDock 
Vina, PatchDock/FireDock and SwissDock. These programs use different approaches 
to model the ligand protein interactions, such as, PatchDock uses shape complemen-
tarity whereas AutoDock 4.2 uses genetic algorithm. Molecular docking analysis by all 
these four programs shows that the interactions of the compound 5 with serum albu-
mins were thermodynamically favorable (Table 4). The binding free energies computed 
by AutoDock Vina and SwissDock are very similar to that of the experimentally obtained 
values (Table  2). Molecular docking also provides the insight into the most favorable 
binding site for these compounds on the serum albumins (Fig. 4). The binding sites for 
Table 3 Molecular properties of the compound
a The data represent mean ± SD
Properties Values
logPa 3.87 ± 0.53
logS −4.86
Polar surface area 94.17 Å2
Lipinski’s rule of five Yes
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the compound lie in the groove between domain I and domain III of BSA, whereas it 
is within the domain I in case of HSA (Fig. 4). Thermodynamics analysis from temper-
ature dependent quenching studies also suggest differential nature of interaction with 
BSA and HSA. Thus, the docking studies which produced two different binding sites for 
HSA and BSA also support the experimentally obtained results (Table 2). Figure 4 also 
Table 4 Theoretical binding free energies as obtained by molecular docking experiments 
using four different algorithms
a The data represent mean ± SEM







BSA −14.37 ± 0.36 −30.96 −47.85 −36.99
HSA −17.34 ± 0.37 −33.47 −54.54 −33.22
Fig. 4 Interaction of the GABA derivative with serum albumins as obtained by molecular modeling. a Bind-
ing site of compound 5 on BSA. b Comparison of the best docked conformations with BSA as obtained by 
AutoDock Vina and AutoDock 4.2. c Comparison of Vina and SwissDock output for compound 5 binding with 
BSA. d PatchDock/FireDock shows Vina output has the best shape complementarity with BSA. e Overlap of 
best docked conformations of compound 5 with BSA. f Binding site of compound 5 on HSA. g Comparison 
of the best HSA binding poses as obtained by AutoDock Vina and AutoDock 4.2. h Comparison of Vina and 
SwissDock output for compound 5 binding with HSA. i PatchDock/FireDock showing Vina output has the 
best shape complementarity with HSA. j Overlap of best docked conformations of compound 5 with HSA. 
Proteins are shown in cartoon diagram and the ligands in stick model. The protein is colored in rainbow from 
N to C terminal. The three domains of serum albumin are marked with I–III. Standard color representation is 
used to denote the elements, H, N and O, in ligand. Ligand C in Vina, AutoDock 4.2, PatchDock/FireDock and 
SwissDock ouput are colored in white, green, cyan and magenta, respectively
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compares the best binding poses obtained by four different docking algorithms. Patch-
Dock is a rigid docking algorithm and, therefore, AutoDock 4.2, Vina and SwissDock 
predicted ligand poses were used as input ligand structures for PatchDock. PatchDock 
results suggests that vina outputs were the best solution among AutoDock 4.2, Vina and 
SwissDock (Fig. 4). AutoDock Vina results, therefore, were used for further analysis and 
in molecular dynamics simulation. 
Figure  5 shows the detailed interaction diagram for the interaction of compound 5 
with BSA and HSA. The figure shows that the interaction with BSA is mainly hydro-
phobic in nature, however, a hydrogen bond formation was observed with Ser428. Resi-
dues from domain I and domain III of BSA are involved in the interaction. On the other 
hand, interaction with HSA was mediated by four hydrogen bonds. The side chain NH 
group of Arg117 of HSA forms a hydrogen bond with the compound 5. Side chain NH of 
Lys137 was found to form two hydrogen bonds and the Tyr161 was also involved to form 
a hydrogen bond with the ligand through the phenolic OH group. Hydrophobic interac-
tions also play a significant role in the interaction of compound 5 and HSA.
Dynamics of compound 5 binding with serum albumins
Molecular dynamics analysis was carried out to further investigate the stability of the 
complex formation. It also allowed us to observe the effect of protein side chain flex-
ibility in the binding site as well as the effect of binding on the overall structure of the 
protein. Figure 6, 7, 8, Additional files 2 and 3 summarize the changes observed during 
the 12 ns time scale of molecular dynamics simulation. Figure 6a, b shows the root mean 
square deviation (RMSD) plots for the BSA and its complex with the ligand. Changes in 
Fig. 5 Detailed interaction of compound 5 with serum albumins. a 2D representation of the compound 
5-BSA interaction diagram as obtained by LigPlot+. Hydrophobic and hydrogen bonding interactions and 
the interacting protein side chain residues are shown. b 2D representation of the compound 5-HSA interac-
tion diagram as obtained by LigPlot+. Hydrophobic and hydrogen bonding interactions and the interacting 
protein side chain residues are shown
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the RMSD values indicated the protein is undergoing a conformational change. How-
ever, changes of the order of 1–3 Å are negligible for small, globular proteins. RMSD 
changes also suggests that the simulation has converged very rapidly and the protein/
complex reached a stable conformation after around 1 ns. Figure 6c shows the changes 
in the radius of gyration of the protein in presence and in absence of the compound. The 
radius of gyration is an indicator of the compactness of the protein. Initially, in presence 
of the ligand BSA showed slightly relaxed conformation (Fig.  6c), however, the struc-
ture converged after about 5  ns and attained a more compact conformation. Figure  7 
also shows the changes in RMSD and the radius of gyration of HSA in presence and in 
absence of the compound.
Fig. 6 Molecular dynamics simulation of BSA-compound 5 complex. a Root mean square deviations (RMSD) 
of atomic positions of BSA backbone with respect to the initial structure, in presence (blue) and absence (red) 
of compound 5. Ligand RMSD with respect to BSA is also shown (yellow). b RMSD of atomic positions of BSA 
side chains with respect to the initial atom positions, in presence (blue) and absence (red) of compound 5. 
RMSD of compound 5 with respect to BSA is also shown. c Change in the radius of gyration of BSA with time 
in presence and absence of compound 5
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Figure  8, on the other hand, highlights the residue-wise fluctuations in the back-
bone and the side chains of BSA and HSA. The ligand contact sites are also highlighted. 
Figure 8 suggests that the backbone fluctuation slightly decreased near the ligand bind-
ing site, both, in BSA and in HSA. Decrease in the backbone fluctuations near the ligand 
indicated that the binding site attained a stable conformation. A video of the dynamics 
of BSA-compound 5 complex is shown in Additional file 2: Video S1. Additional file 3: 
Video S2 shows the dynamics of HSA-compound 5 in water.
Over the course of simulation, the ligand makes stable as well as transient contacts 
with the surrounding residues at the binding site. Such ligand contacts over the simula-
tion time scale are depicted in Figs.  9 and 10. Figure  9 summarizes the contacts with 
BSA. From this figure it appears that Arg458 of BSA forms most contacts with the 
Fig. 7 Molecular dynamics simulation of HSA-compound 5 complex. a RMSD of atomic positions of HSA 
backbone with respect to the initial structure, in presence (blue) and absence (red) of compound 5. RMSD of 
compound 5 with respect to HSA is also shown (yellow). b RMSD of atomic positions of HSA side chains with 
respect to the initial atom positions, in presence (blue) and absence (red) of compound 5. RMSD of com-
pound 5 with respect to HSA is also shown. c Change in the radius of gyration of HSA with time in presence 
and absence of compound 5
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ligand. It forms hydrogen bonds, ionic interactions as well as water bridges with the 
compound 5. Other residues that were fund to form hydrogen bonds were Leu189 and 





Fig. 8 Fluctuations in the protein backbone and side chains when bound to compound 5. a Root mean 
square fluctuations (RMSF) in the backbone of BSA in presence (blue) and absence (red) of compound 5. 
Ligand contact sites are shown with vertical yellow lines. b RMSF in the side chains of BSA in presence and 
absence of compound 5. Ligand contact sites are shown. c RMSF in the backbone of HSA in presence and 
absence of compound 5. Ligand contact sites are shown. b RMSF in the side chains of HSA in presence and 
absence of compound 5. Ligand contact sites are shown
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Figure 10 summarizes the contacts with HSA. The residues that maintained consistent 
contacts over the simulation were Tyr161, Arg117 and Tyr138. The first two form pre-
dominantly hydrogens bonds whereas the Tyr138 provides hydrophobic environment.
Conclusion
We have reported here, the synthesis and physicochemical properties of a new deriva-
tive of the naturally occurring inhibitory neurotransmitter GABA and its interactions 
with the drug carrier protein in blood, the serum albumin. Binding of this molecule with 
two orthologs of serum albumins, human and bovine, were compared. The compound 
shows drug like properties and binds to the human and bovine serum albumins with 
Fig. 9 Ligand contacts with BSA over the time frame of molecular dynamics simulation. Number of hydro-
gen bonds, hydrophobic, ionic interactions and water bridges are measured. The top panel shows the total 
number of specific contacts BSA makes with compound 5 over the course of the trajectory. The bottom panel 
shows which residues of BSA interact with compound 5 in each trajectory frame. Some residues make more 
than one specific contact with the ligand, which is represented by a darker shade of orange, according to the 
scale to the right of the plot
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the binding constants in low micromolar concentration range. Thermodynamics analysis 
showed that the binding of compound 5 with HSA was enthalpy driven, whereas binding 
with BSA was driven by entropy. Molecular docking studies by various different algo-
rithms further showed that the compound binds to the groove between domain I and 
domain III of BSA and within the domain I in case of HSA. Molecular dynamics analysis 
showed that the compound forms stable complexes with the serum albumins. Binding 
of the compound with BSA was stabilized mainly by hydrophobic and ionic interac-
tions, whereas, interactions with HSA was maintained predominantly through hydrogen 
bonding.
Additional files
Additional file 1: Detailed procedure of the synthesis of methyl 4-(4-((2-(tert-butoxy)-2-oxoethyl)(4-methoxyphe-
nyl)amino)benzamido)butanoate and the characteristic data. 1H and 13C NMR spectra of the compound are also 
given in the Additional file 1. It also contains Figure S1 and Table S1.
Additional file 2: The dynamics of BSA-compound 5 in water over the course of 12 ns time is shown in Video S1.
Additional file 3: The dynamics of HSA-compound 5 in water over the course of 12 ns time is shown in Video S2.
Fig. 10 Ligand contacts with HSA over the time frame of molecular dynamics simulation. Number of hydro-
gen bonds, hydrophobic, ionic interactions and water bridges are measured. The top panel shows the total 
number of specific contacts HSA makes with compound 5 over the course of the trajectory. The bottom panel 
shows which residues of HSA interact with compound 5 in each trajectory frame. Some residues make more 
than one specific contact with the ligand, which is represented by a darker shade of orange, according to the 
scale to the right of the plot
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